证券记录 · 已归档季度
INSP
Inspire Medical Systems, Inc. · Healthcare · Medical - Devices
16被追踪持有人
+1Δ持有人
4.78M持有股份
$1.01B报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +6.7% ·
股份流向 -6.2% ·
净新建仓位 +6.2%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | -1 | 27.80M | $1.24B | +14 | −14 |
| Q1 2026 | 102 | -7 | 22.50M | $1.16B | +11 | −19 |
| Q4 2025 | 110 | 0 | 24.43M | $2.25B | +3 | −2 |
| Q3 2025 | 20 | +2 | 13.81M | $1.03B | +2 | −1 |
| Q2 2025 | 16 | -1 | 12.85M | $1.67B | +1 | −2 |
| Q1 2025 | 14 | -1 | 3.76M | $597.97M | — | −1 |
| Q4 2024 | 15 | -2 | 4.14M | $766.98M | — | −2 |
| Q3 2024 | 16 | +1 | 4.78M | $1.01B | +1 | — |
| Q2 2024 | 15 | — | 5.10M | $682.73M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 1.39M | -29.5% | $293.85M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.39M | -29.5% | $293.85M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.39M | -29.5% | $293.85M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.39M | -29.5% | $293.85M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.39M | -29.5% | $293.85M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 1.37M | -4.2% | $288.47M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 1.37M | -4.2% | $288.47M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 1.37M | -4.2% | $288.47M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 1.37M | -4.2% | $288.47M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (被动) | 483.65K | +0.7% | $102.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 483.65K | +0.7% | $102.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 446.41K | +92.5% | $93.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 446.41K | +92.5% | $93.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 446.41K | +92.5% | $93.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 319.36K | +954.4% | $67.40M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (被动) | 277.97K | 0.0% | $58.67M | 0.0% | Held | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 164.10K | -55.0% | $34.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 164.10K | -55.0% | $34.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 110.31K | +248.5% | $23.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 110.31K | +248.5% | $23.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Renaissance Technologies ✦ | 100.50K | +36.5% | $21.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 75.00K | -11.8% | $15.83M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 14.99K | -32.8% | $3.16M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Marshall Wace ✦ | 14.78K | -63.5% | $3.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Millennium Management ✦ | 7.53K | -76.7% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Bridgewater Associates ✦ | 4.54K | -14.2% | $958,167 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 2.97K | -87.2% | $627,452 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 2.97K | -87.2% | $627,452 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Arrowstreet Capital ✦ | 2.09K | 新增 | $441,517 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $441,517 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 298 持有人, 34.81M 股份, $1.75B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 07
Kelly Jason P
Officer · 963 股 · $57,347
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A — Soleus Capital Master Fund, L.P.
Aug 12
SC 13G — AQR CAPITAL MANAGEMENT LLC
Jul 31
SC 13G/A — VANGUARD PORTFOLIO MANAGEMENT LLC
Jul 28
SC 13G/A — BlackRock, Inc.
Jul 02
SC 13G — D. E. SHAW & CO, L.P.
May 27
SC 13G — Soleus Capital Master Fund, L.P.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据